1. Sirtuin 1 Activator SRT1720 Protects Against Lung Injury via Reduction of Type II Alveolar Epithelial Cells Apoptosis in Emphysema
    Chao Gu et al, 2015, COPD: Journal of Chronic Obstructive Pulmonary Disease CrossRef
  2. Sirt1 protects from K‐Ras‐driven lung carcinogenesis
    Luis Filipe Costa‐Machado et al, 2018, EMBO reports CrossRef
  3. Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1
    Julia Slanovc et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  4. A Novel Necroptosis-Associated IncRNAs Signature for Prognosis of Head and Neck Squamous Cell Carcinoma
    Jing Huang et al, 2022, Frontiers in Genetics CrossRef
  5. Elaiophylin Inhibits Tumorigenesis of Human Lung Adenocarcinoma by Inhibiting Mitophagy via Suppression of SIRT1/Nrf2 Signaling
    Jiali Ji et al, 2022, Cancers CrossRef
  6. Hydroquinone-induced malignant transformation of TK6 cells by facilitating SIRT1-mediated p53 degradation and up-regulating KRAS
    Yuting Chen et al, 2016, Toxicology Letters CrossRef
  7. SIRT1 promotes metastasis of human osteosarcoma cells
    Ning Zhang et al, 2016, Oncotarget CrossRef
  8. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun et al, 2019, Frontiers in Endocrinology CrossRef
  9. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
    Silvia Juliana Serrano-Gomez et al, 2016, Molecular Cancer CrossRef
  10. Epigenetics and precision medicine in bone and soft tissue sarcomas
    Kaniz Fatema et al, 2022, Epigenetics in Precision Medicine CrossRef
  11. Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
    Juhong Yang et al, 2017, Journal of Diabetes and its Complications CrossRef
  12. SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
    Rui Xu et al, 2021, Frontiers in Oncology CrossRef
  13. Sirtuin1 Expression and Correlation with Histopathological Features in Retinoblastoma
    Atul Batra et al, 2016, Ocular Oncology and Pathology CrossRef
  14. Increased PPARD Expression May Play a Protective Role in Human Lung Adenocarcinoma and Squamous Cell Carcinoma
    Yong Zhu et al, 2022, PPAR Research CrossRef
  15. Development of Activity-Based Chemical Probes for Human Sirtuins
    Elysian Graham et al, 2018, ACS Chemical Biology CrossRef
  16. Deacetylation-activated construction of single quantum dot-based nanosensor for sirtuin 1 assay
    Juan Hu et al, 2021, Talanta CrossRef
  17. SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity
    Ji An Kang et al, 2024, Experimental & Molecular Medicine CrossRef
  18. Effects of SIRT1 silencing on viability, invasion and metastasis of human glioma cell lines
    Yu Li et al, 2019, Oncology Letters CrossRef
  19. SIRT1: An Intermediator of Key Pathways Regulating Pulmonary Diseases
    Yi-Zhu Jiang et al, 2024, Laboratory Investigation CrossRef
  20. Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis
    Yifei Chen et al, 2017, Oncotarget CrossRef
  21. Understanding the Correlation between Metabolic Regulator SIRT1 and Exosomes with CA-125 in Ovarian Cancer: A Clinicopathological Study
    Sraddhya Roy et al, 2022, BioMed Research International CrossRef
  22. Expression of SIRT1 and SIRT3 varies according to age in mice
    Youngho Kwon et al, 2015, Anatomy & Cell Biology CrossRef